Nibbled on $TGTX and will add heavily on any breakout:
I believe it was Rob or Doc who brought this one to the board’s attention earlier this week or late last week. I’m liking the setup for a breakout. High SCTR, above the 250 EMA, 20 x 50 EMA bullish crossover which went into effect back in NOV 2022 is still intact.
I have no idea what these guys are into, but, I guess I’ll find out tonight.
They are working on a monoclonal antibody for Multiple Sclerosis. It looks like they will report results on phase 1 and 2 trials in April so this stock should be up and down for months…doc
Guessing Rob’s find but here are the recent financials: TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates - February 28, 2023 - Zacks.com
Studies:
https://www.tgtherapeutics.com/publications/
TGTX press releases:
I don’t remember any typo where I commented on TGTX, but maybe I’m mistaken.
I do own TMDX though. Completely different. Involved with organ transplants.
Rob
He is no fool who gives what he cannot keep to gain what he cannot lose.
Sold my last remaining shares of $HAL and missed getting more $ARDX in the pre-market.
Check out the earnings report for $ARDX I just laid on the board.
Added some $TTD
Nibbled on some $BBAI and might go full load if it holds this new breakout.
Nibbled on $CYH
Raised $BOIL stop/loss to $7.25 (carrying a 78% gain thusfar) on these last shares. I’m in.
Why I nibbled on $BBAI earlier today:
$BBAI daily chart shows 2x avg daily volume and a downtrend reversal breakout. This one is trading just below the 250 EMA, but, it’s also maintaining a higher SCTR (96.5 now, but changes throughout a trading day) and that’s one reason I’m buying despite not being above the 250 EMA.
$TGTX daily chart showing big breakout on below avg. daily volume. Going to hold onto this one to see what next week brings. Give us some higher volume and I cn see a new 52-Week High in the cards:
